These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32506380)

  • 21. Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development.
    Nakayama K; Nakayama K
    Bioessays; 1998 Dec; 20(12):1020-9. PubMed ID: 10048302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.
    Zabihi M; Lotfi R; Yousefi AM; Bashash D
    J Cancer Res Clin Oncol; 2023 Apr; 149(4):1585-1606. PubMed ID: 35781526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.
    Bonelli P; Tuccillo FM; Borrelli A; Schiattarella A; Buonaguro FM
    Biomed Res Int; 2014; 2014():361020. PubMed ID: 24605326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).
    Perez-Roger I; Kim SH; Griffiths B; Sewing A; Land H
    EMBO J; 1999 Oct; 18(19):5310-20. PubMed ID: 10508164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin-dependent kinases in cancer: Role, regulation, and therapeutic targeting.
    Gupta A; Dagar G; Chauhan R; Sadida HQ; Almarzooqi SK; Hashem S; Uddin S; Macha MA; Akil ASA; Pandita TK; Bhat AA; Singh M
    Adv Protein Chem Struct Biol; 2023; 135():21-55. PubMed ID: 37061333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel plant-specific cyclin-dependent kinase inhibitors induced by biotic and abiotic stresses.
    Peres A; Churchman ML; Hariharan S; Himanen K; Verkest A; Vandepoele K; Magyar Z; Hatzfeld Y; Van Der Schueren E; Beemster GT; Frankard V; Larkin JC; Inzé D; De Veylder L
    J Biol Chem; 2007 Aug; 282(35):25588-96. PubMed ID: 17599908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of cyclins and cyclin-dependent kinases in pluripotent stem cells and their potential as a therapeutic target.
    Jirawatnotai S; Dalton S; Wattanapanitch M
    Semin Cell Dev Biol; 2020 Nov; 107():63-71. PubMed ID: 32417217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin.
    Rodriguez-Puebla ML; LaCava M; Gimenez-Conti IB; Johnson DG; Conti CJ
    Oncogene; 1998 Oct; 17(17):2251-8. PubMed ID: 9811455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.
    Arooz T; Yam CH; Siu WY; Lau A; Li KK; Poon RY
    Biochemistry; 2000 Aug; 39(31):9494-501. PubMed ID: 10924145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes.
    Mouriaux F; Casagrande F; Pillaire MJ; Manenti S; Malecaze F; Darbon JM
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):876-84. PubMed ID: 9579467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle control in isoproterenol-induced murine salivary acinar cell proliferation.
    Zeng T; Yamamoto H; Bowen E; Broverman RL; Nguyen KH; Humphreys-Beher MG
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1996 Nov; 115(3):271-9. PubMed ID: 9375366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of CDKs and CDKIs in Murine Development.
    Campbell GJ; Hands EL; Van de Pette M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes.
    Morris MC; Divita G
    J Mol Biol; 1999 Feb; 286(2):475-87. PubMed ID: 9973565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cdk pathway: cyclin-dependent kinases and cyclin-dependent kinase inhibitors.
    Gitig DM; Koff A
    Mol Biotechnol; 2001 Oct; 19(2):179-88. PubMed ID: 11725487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclins and related kinases in cancer cells.
    Malumbres M
    J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural dissection of cyclin dependent kinases regulation and protein recognition properties.
    Lolli G
    Cell Cycle; 2010 Apr; 9(8):1551-61. PubMed ID: 20372077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.